NCT07700251 Retrograde Intrarenal Surgery Versus Mini Percutaneous Nephrolithotomy
| NCT ID | NCT07700251 |
| Status | Recruiting |
| Phase | — |
| Sponsor | South Valley University |
| Condition | Pediatric Renal Stone |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-08-01 |
| Primary Completion | 2026-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-08-01 with a primary completion date of 2026-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Pediatric nephrolithiasis accounts for approximately 2-3% of all stone disease cases, with recent reports indicating a rising prevalence of up to 10.6%. This increasing incidence poses a growing public health concern. The primary objective in managing pediatric renal stones is complete stone clearance while minimizing complications and improving the patient's quality of life.
Eligibility Criteria
Inclusion Criteria: * Children aged 1 to 18 years . * Presence of a renal stone ≤2 cm in maximum diameter (single or multiple). * Stone located in the renal pelvis and/or calyces. * Normal renal function (based on age-adjusted serum creatinine and/or eGFR). * No prior surgical intervention for the current stone episode. Exclusion Criteria: * Anatomical abnormalities of the urinary tract (e.g., ureteropelvic junction obstruction, horseshoe kidney). * Bleeding disorders or uncorrected coagulopathy. * Active urinary tract infection at the time of surgery. * Patients with contraindications to general anesthesia.
Contact & Investigator
Gamal Abdelhamid Alsagheer, Professor
STUDY CHAIR
Urology Department, Faculty of Medicine, South Valley University.
Frequently Asked Questions
Who can join the NCT07700251 clinical trial?
This trial is open to participants of all sexes, aged 1 Year or older, up to 18 Years, studying Pediatric Renal Stone. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07700251 currently recruiting?
Yes, NCT07700251 is actively recruiting participants. Contact the research team at Mostafarashed2222@gmail.com for enrollment information.
Where is the NCT07700251 trial being conducted?
This trial is being conducted at Qina, Egypt.
Who is sponsoring the NCT07700251 clinical trial?
NCT07700251 is sponsored by South Valley University. The principal investigator is Gamal Abdelhamid Alsagheer, Professor at Urology Department, Faculty of Medicine, South Valley University.. The trial plans to enroll 60 participants.